Details of the Drug

General Information of Drug (ID: DMT7P2Z)

• Drug Name: 1-(oxazolo[4,5-b]pyridin-2-yl)dodecan-1-one
• Synonyms: 1-OXAZOLO[4,5-B]PYRIDIN-2-YL-1-DODECANONE; 288862-73-7; CHEMBL257307; SCHEMBL3964457; MolPort-009-018-944; HMS3649B18; BDBM50350547; 1312AH; ZINC34803705; AKOS027301548; ACM288862737; SR-01000946699; 1-[1,3]oxazolo[4,5-b]pyridin-2-yldodecan-1-one

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 2:
  Molecular Weight (mw); 302.4
  Logarithm of the Partition Coefficient (xlogp); 6.2
  Rotatable Bond Count (rotbonds); 11
  Hydrogen Bond Donor Count (hbonddonor); 0
  Hydrogen Bond Acceptor Count (hbondacc); 4
• Chemical Identifiers:
  Formula: C18H26N2O2
  IUPAC Name: 1-([1,3]oxazolo[4,5-b]pyridin-2-yl)dodecan-1-one
  Canonical SMILES: CCCCCCCCCCCC(=O)C1=NC2=C(O1)C=CC=N2
  InChI: InChI=1S/C18H26N2O2/c1-2-3-4-5-6-7-8-9-10-12-15(21)18-20-17-16(22-18)13-11-14-19-17/h11,13-14H,2-10,12H2,1H3
  InChIKey: XUWBDQAPIZBSRY-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 9972176
  TTD ID: D0X8ZO

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Fatty acid amide hydrolase (FAAH)	TTDP1UC	NOUNIPROTAC	Inhibitor	[1]

Molecular Expression Atlas of This Drug

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Fatty acid amide hydrolase (FAAH)	DTT	NO-GeName	2.65E-01	0.02	0.1

References

• [1] Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality. Bioorg Med Chem. 2008 Feb 15;16(4):1562-95.